S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.

Jiao X, Zhang H, Xu X, Yu Y, Zhang H, Zhang J, Ning L, Hao F, Liu X, Niu M, Chen CT, Chen D, Zhang K

DOI: 10.1159/000493296
Published: 2018
Container: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 25/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1159/000493296,
  title = {S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.},
  author = {Jiao X and Zhang H and Xu X and Yu Y and Zhang H and Zhang J and Ning L and Hao F and Liu X and Niu M and Chen CT and Chen D and Zhang K},
  year = {2018},
  journal = {Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology},
  doi = {10.1159/000493296},
  url = {https://doi.org/10.1159/000493296}
}

RIS

TY  - JOUR
TI  - S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.
AU  - Jiao X
AU  - Zhang H
AU  - Xu X
AU  - Yu Y
AU  - Zhang H
AU  - Zhang J
AU  - Ning L
AU  - Hao F
AU  - Liu X
AU  - Niu M
AU  - Chen CT
AU  - Chen D
AU  - Zhang K
PY  - 2018
JO  - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology
DO  - 10.1159/000493296
UR  - https://doi.org/10.1159/000493296
ER  -

APA

X, J., H, Z., X, X., Y, Y., H, Z., J, Z., L, N., F, H., X, L., M, N., CT, C., D, C., & K, Z. (2018). S100A4 Knockout Sensitizes Anaplastic Thyroid Carcinoma Cells Harboring BRAFV600E/Mt to Vemurafenib.. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. https://doi.org/10.1159/000493296

Source records

pubmed · retrieved 2026-09-25T04:30:38.704Z